The authors reply
- PMID: 35612454
- DOI: 10.1097/CCM.0000000000005529
The authors reply
Conflict of interest statement
Dr. Bleck received funding from Sage Therapeutics and Marinus Pharmaceuticals. Dr. Chang disclosed that she is employed by Duke University, is on the Council of Society of Critical Care Medicine (SCCM), and is on the Board of Directors of the Rehabilitation Hospital of the Pacific. Dr. Deutschman’s institution received funding from SCCM; he received funding from the National Institute of General Medical Sciences, ICON Data Management, Enlivex, La Jolla Pharmaceuticals, and Elsevier. Drs. Kadri and Masur received support for article research from the National Institutes of Health (NIH). Dr. Osborn received funding from Beckman, Inflammatix, Northwest Anesthesia Seminars, and Abbott; she disclosed that she has worked with the Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services, and American College of Emergency Physicians. Dr. Sarwal’s institution received funding from LungPacer; she received funding from SCCM, the Neurocritical Care Society, the American Academy of Neurology, the American Association for Physical Therapists, and Chest and American Thoracic Society, Neuroscience Clinical Trials & Innovation Center, Clinical Translational Science Institute Atrium pilot grant, and Neurology Center, MD; she disclosed that she is Site Investigator for clinical trials sponsored by Novartis/IQVIA (Saponimod), Bard (Impact of Fever Prevention in Brain Injured Patients [INTREPID]), and Biogen (Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 [Glibenclamide] for Severe Cerebral Edema Following Large Hemispheric Infarction [CHARM] AegisCN LLC. She is a Research Ultrasound Consultant for clinical trial R01 AG066910-01 NIH/National Institutes on Aging Brinkley/Shaltout (principal investigator) 04/01/20-03/31/25, holds a mentor role for the American Academy of Neurology Medical Student Research Scholarship, and that she is a Social Media Editor for SCCM and Neurocritical Care. Dr. Sevransky’s institution received funding from the Marcus Foundation, the Centers for Disease Control and Prevention Foundation, and Health & Human Services. Dr. Thiagarajan received funding from SCCM Pediatric Board Review Course and Extracorporeal Life Support Organization. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Comment on
-
Further Retractions of Articles by Joachim Boldt.Crit Care Med. 2022 Jun 1;50(6):e601-e603. doi: 10.1097/CCM.0000000000005506. Epub 2022 May 19. Crit Care Med. 2022. PMID: 35612453 No abstract available.
References
-
- Motta M, Stecula D: Quantifying the effect of Wakefield et al . (1998) on skepticism about MMR vaccine safety in the U.S. PLoS One 2021; 16:e0256395
-
- Zarychanski R, Abou-Setta AM, Turgeon AF, et al.: Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: A systematic review and meta-analysis. JAMA 2013; 309:678–688
-
- Wiedermann CJ: Further Retractions of Articles by Joachim Boldt. Crit Care Med. 2022; 50:e601–e603
Publication types
LinkOut - more resources
Full Text Sources